Registration Dossier

Administrative data

Description of key information

Oral route: LD50 = 2000 mg/kg bw

Inhalation route: LC50 (4h) > 3.30 mg/L

Dermal route: LD50 > 2000 mg/kg bw

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50
2 000 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LC50
3 300 mg/m³

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
2 000 mg/kg bw

Additional information

See attached document.

Justification for classification or non-classification

The substance is classified as Category 4 for Acute Toxicity according to the CLP Regulation (EC.1272/2008). For justification see additional information.